How many bowel movements a week counts as constipation?

MedlinePlus defines it as "having fewer than three bowel movements a week," with stool that can be hard and dry. NIDDK adds stools that are lumpy, difficult or painful to pass, or leave a feeling that not everything came out. Track your own baseline, because a drop from daily to every third day matters even if the count still clears three.

Can I take a fiber supplement at the same time as my Ozempic shot?

Ozempic is a weekly injection, so it does not compete with an oral supplement in your stomach the way a pill would. The label does note that Ozempic delays gastric emptying and may affect the absorption of oral medications, and it advises caution with concomitant oral drugs. Ask your pharmacist about spacing fiber away from any oral prescriptions, and drink extra fluid whenever you add fiber.

Should I lower my Ozempic dose to fix constipation?

That is a prescriber decision, not a self-adjustment. The label shows total gastrointestinal reactions rising from 32.7% on 0.5 mg to 36.4% on 1 mg, so dose does matter. It also sets a minimum of 4 weeks at each step before escalating, which gives your gut time to adapt.

Is constipation a reason to stop Ozempic completely?

Usually not on its own. In the placebo-controlled trials, 3.1% of people on 0.5 mg and 3.8% on 1 mg stopped for gastrointestinal reasons of any kind, versus 0.4% on placebo. Severe or blocking symptoms are a different matter and need an urgent clinical assessment.

Does drinking more water alone fix it?

Rarely by itself. NIDDK pairs fluid with fiber and physical activity, and specifically ties extra liquid to any increase in fiber. Water helps most when it is added alongside the other two changes, not instead of them.

Why Does Ozempic Cause Constipation and What Actually Helps?

The short answer: Ozempic (semaglutide) slows how fast food leaves your stomach and moves through your gut. Stool sits longer in the colon, and the colon pulls more water out of it. In the FDA placebo-controlled trials, constipation was reported by 5% of people on Ozempic 0.5 mg and 3.1% on 1 mg, against 1.5% on placebo. Fluid, fiber, and daily movement come first. Call a clinician if you cannot pass gas or stool and you have vomiting or severe pain.

Why does Ozempic cause constipation?

Ozempic is semaglutide, a GLP-1 receptor agonist. The FDA-approved Ozempic label names the mechanism in Clinical Pharmacology: "Semaglutide causes a delay of early postprandial gastric emptying, thereby reducing the rate at which glucose appears in the circulation postprandially."

That is the stomach. Constipation happens in the colon. Small studies suggest GLP-1 medicines slow the whole gut. In a Cleveland Clinic wireless motility capsule case series of 10 patients on GLP-1 receptor agonists, gastric emptying was delayed in 80%, whole-gut transit in 44%, and colonic transit in 33%. The three patients on semaglutide 1 mg had the longest gastric emptying times. Ten patients is a tiny sample, so read it as a signal, not a settled number.

Slow transit is only half the story. The longer stool stays in the colon, the more water the colon absorbs, and the harder it becomes. Behavior pushes the same way. People on Ozempic eat less fiber, and many drink less, because appetite and thirst cues fade together. NIDDK lists not enough fiber, not enough liquids, and not enough physical activity among the causes of constipation. Ozempic can quietly create all three.

How common is constipation on Ozempic?

MedlinePlus defines constipation as "having fewer than three bowel movements a week." On Ozempic it makes the label's top-five list: "the most common adverse reactions reported in ≥5% of patients treated with OZEMPIC are: nausea, vomiting, diarrhea, abdominal pain and constipation."

Table 1 of the Ozempic prescribing information pools two placebo-controlled type 2 diabetes trials, with 521 patients exposed for a mean of 32.9 weeks. The constipation row reads:

Placebo (N=262): 1.5%
Ozempic 0.5 mg (N=260): 5%
Ozempic 1 mg (N=261): 3.1%

The 1 mg figure is lower than the 0.5 mg figure. That is a quirk of these two trials, not a dose-response pattern. Total gastrointestinal reactions did climb with dose: 15.3% on placebo, 32.7% on 0.5 mg, and 36.4% on 1 mg.

The label gives no separate constipation percentage for the 2 mg dose or the other two approved indications. In the 40-week trial of 959 patients comparing 1 mg and 2 mg, it reports only that gastrointestinal reactions hit 34% on 2 mg versus 30.8% on 1 mg. For the cardiovascular outcomes trial, common reactions "were similar to those listed in Table 1." In the FLOW kidney trial behind the chronic kidney disease indication, "safety data collection was limited to serious adverse events."

Severe gut reactions are uncommon: 0.4% on 0.5 mg and 0.8% on 1 mg, versus 0% on placebo. Discontinuation for gastrointestinal reasons hit 3.1% on 0.5 mg and 3.8% on 1 mg, versus 0.4% on placebo.

When does it start, and does it get better?

The label gives a timing statement for the other gut effects, but not for constipation. It says "the majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation." Ozempic starts at 0.25 mg weekly for 4 weeks, then steps to 0.5 mg, and can reach 1 mg and 2 mg after at least 4 weeks at each step. Every step raises exposure, and each one is where people notice a change.

Constipation often follows the same rhythm, though the label attaches no number to that. What the label does show is that most people keep going: fewer than 4% stopped for gastrointestinal reasons in the placebo-controlled pool. Our guide to Ozempic side effects management covers the dose-escalation window in more detail.

What actually helps?

The standard constipation playbook applies. NIDDK puts three habits first.

Fiber. "Depending on your age and sex, adults should get 22 to 34 grams of fiber a day." You are eating less on Ozempic, so fiber has to be deliberate rather than incidental. Our Ozempic food plan covers how to fit fiber into a smaller appetite.
Fluid. NIDDK says to "drink plenty of water and other liquids if you eat more fiber or take a fiber supplement." Adding fiber without adding fluid can make things worse.
Movement. "Getting regular physical activity may help relieve your symptoms."

When habits are not enough, over-the-counter products come next. That is a conversation for your pharmacist or prescriber. NIDDK sorts them into fiber supplements, osmotic agents, stool softeners, lubricants, and stimulants, with one caution: "You should only use stimulants if your constipation is severe or other treatments have not worked."

The joint AGA and ACG guideline on chronic idiopathic constipation follows the same order. Fiber first, then an osmotic laxative such as polyethylene glycol, magnesium oxide, or lactulose, then a stimulant such as bisacodyl or senna for short-term rescue. Prescription agents come after that. It gives strong recommendations to polyethylene glycol, bisacodyl, sodium picosulfate, linaclotide, plecanatide, and prucalopride, and conditional recommendations to fiber, magnesium oxide, lactulose, senna, and lubiprostone. That guidance covers chronic constipation in general, not drug-induced constipation, and it is not a dosing plan.

What makes Ozempic constipation worse?

Dose escalation. Gastrointestinal reactions rose from 32.7% on 0.5 mg to 36.4% on 1 mg. Do not change your dose on your own to chase relief.
Eating and drinking too little. Appetite suppression is the point of the drug. It is also the fastest route to a low-fiber, low-fluid day.
Other constipating medicines. NIDDK names antacids containing aluminum and calcium, anticholinergics, anticonvulsants, calcium channel blockers, diuretics, iron supplements, narcotic pain medicines, some antidepressants, and medicines for Parkinson's disease.
Ignoring the urge, and sitting still. Both appear on the NIDDK cause list in their own right.

Constipation is a class effect, not an Ozempic quirk. The site glp1.md tracks the shared gastrointestinal profile across GLP-1 medicines.

When should you stop and call a clinician?

Most constipation is a nuisance. Some is not. The FDA has twice added bowel-blockage terms to the semaglutide label. Its Drug Safety-related Labeling Changes record shows "Gastrointestinal Disorders: Ileus" added to the Postmarketing Experience section on September 22, 2023. On January 28, 2025 that line grew to "ileus, intestinal obstruction, severe constipation including fecal impaction." Ileus means the bowel stops pushing contents forward. The label notes these reports arrive "voluntarily from a population of uncertain size," so their frequency and causal link cannot be established.

A 2023 JAMA cohort study of 4,144 liraglutide users, 613 semaglutide users, and 654 people on bupropion-naltrexone linked GLP-1 use for weight loss to higher rates of bowel obstruction (hazard ratio 4.22; 95% CI, 1.02 to 17.40) and gastroparesis (hazard ratio 3.67; 95% CI, 1.15 to 11.90). Note the very wide first interval, and zero bowel obstruction cases in the semaglutide group.

NIDDK says to see a doctor right away if constipation comes with any of these: "bleeding from your rectum; blood in your stool; constant pain in your abdomen; inability to pass gas; vomiting; fever; lower back pain; losing weight without trying." On a GLP-1 medicine, the pattern that matters most is no bowel movement and no gas, with vomiting or severe abdominal pain. That can mean ileus or obstruction. It belongs in urgent care or an emergency room, not on another laxative.

Section 5.7 adds one more line: "OZEMPIC is not recommended in patients with severe gastroparesis." Our article on Ozempic and gastroparesis explains how that condition overlaps with slow-transit symptoms.

The bottom line

Ozempic constipation comes from slower gut transit plus a smaller, drier diet. The FDA label reports it in 5% of people on 0.5 mg and 3.1% on 1 mg, versus 1.5% on placebo. Fluid, 22 to 34 grams of fiber a day, and regular movement come first. Osmotic and then stimulant laxatives are the usual next categories, chosen by your pharmacist or prescriber. Treat no stool and no gas with vomiting or severe abdominal pain as an emergency.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. It gives no laxative dosing. Talk to your prescriber or pharmacist before starting any laxative, changing your Ozempic dose, or stopping the medicine.